Cannabis Stem Extract Counters BPA Effects in Cells

Cannabis research usually begins with the flower. That is where THC, CBD, and many of the plant’s best-known compounds are concentrated, so it naturally attracts most scientific and commercial attention. A new study suggests that the largely overlooked stem may also deserve a closer look.

Researchers found that an ethanol extract made from Cannabis sativa stems interfered with several cellular effects caused by bisphenol A, better known as BPA.¹ In an estrogen receptor-positive human breast cancer cell line, the extract reduced estrogen receptor alpha activity, suppressed BPA-induced cell proliferation, and moderated a signalling pathway associated with cellular growth.

The findings do not show that cannabis stems prevent cancer, remove BPA from the body, or protect people who consume them. This was an early laboratory experiment involving cultured cells. What it does show is that non-intoxicating and commonly discarded parts of cannabis may contain biologically active compounds worthy of further study.

Why Researchers Studied Cannabis Stems and BPA

BPA is an industrial chemical used in certain plastics, resins, and food-contact materials. It has attracted scientific attention because it can interact with hormone signalling. Readers looking for regulatory context can review Health Canada’s overview of bisphenol A, which explains how Canadian authorities assess exposure through food packaging.

The new study focused on estrogen receptor alpha, or ERα. This receptor normally helps cells respond to estrogen, but other substances can activate or disrupt the same system. BPA can behave as an external estrogen-like signal under experimental conditions. In estrogen-sensitive cells, that activity may influence gene transcription and growth-related pathways.

The researchers paired that problem with an underused resource: cannabis stems. Flowers and leaves are commonly studied for cannabinoids and flavonoids, while seeds receive attention as food ingredients. Stems are more often treated as fibre feedstock or agricultural residue. Their low-value status does not mean they are chemically empty. Stem tissue contains its own mixture of secondary metabolites, even when THC is undetectable.

This whole-plant perspective is increasingly important to the hemp sector. Recent MyCannabis coverage has explored how hemp residues can become biochar or energy feedstocks and how hemp protein waste can support biodegradable materials. The new research adds a biological application to that circular-economy discussion.

How Cannabis Stem Extract Changed Cellular Signalling

The team prepared a Cannabis sativa stem ethanol extract, abbreviated as CSE, and tested it in VM7Luc4E2 cells. This human breast cancer cell line expresses estrogen receptor alpha and is used to detect substances that activate or inhibit the receptor.

The receptor assay followed the framework of OECD Test Guideline 455. This matters because the assay was not simply an informal observation that fewer cells remained after treatment. It was designed to examine whether the extract acted as an antagonist to estrogen-receptor activity.

CSE inhibited BPA-induced ERα transcriptional activation and eliminated the increase in viable cell density observed after BPA exposure. The researchers then examined five prominent compounds previously identified in the extract. Three demonstrated estrogen-receptor antagonistic potential: cyclopentane-1,2-dione, or CPD; 4-vinylguaiacol, or 4-VG; and 4-([1E]-hydroxy-1-propenyl)-2-methoxyphenol, or 4-HMP.

The distinction between these compounds is significant. They reached a similar broad outcome through apparently different routes. CPD did not significantly reduce the movement of ERα into the nucleus, suggesting that it may interfere earlier with receptor activation or dimerization. By contrast, 4-VG and 4-HMP reduced the amount of ERα reaching the nucleus, where the receptor can influence gene expression.

One Extract, More Than One Mechanism

The study also examined the p38 branch of the mitogen-activated protein kinase, or MAPK, pathway. BPA increased p38 phosphorylation, a chemical change that helps transmit growth-related signals inside the cell. Cannabis stem extract and all three identified compounds reduced this response.

Together, the experiments point to several connected effects:

• Lower estrogen receptor transcriptional activity
• Less BPA-associated proliferation in the tested cells
• Reduced p38 activation within a growth-related pathway
• Different receptor effects among the three active compounds

That complexity may ultimately matter more than the performance of any single molecule. Plant extracts contain mixtures whose components can complement, weaken, or alter one another. The researchers identified three candidates, but they did not establish that these compounds alone explain the full activity of the extract. Future work will need to test them individually and in mixtures matching the proportions actually found in stems.

What the Study Does Not Establish

The phrase “breast cancer cells” can make laboratory results sound more clinically advanced than they are. In this case, the cells served as an estrogen-responsive testing model. The experiment was not a cancer treatment trial, and it did not demonstrate tumour reduction in animals or humans.

There is also a major gap between adding an extract directly to cultured cells and consuming a stem-derived product. A compound taken orally must survive digestion, enter circulation, reach the relevant tissue, and remain present at an effective concentration without creating unacceptable side effects. The paper notes that human pharmacokinetic data for the active compounds remain limited. It is unknown whether free CPD, 4-VG, or 4-HMP could reach concentrations comparable to those used in the experiments.

The exposure design creates another boundary. Cells received BPA for 48 hours and were then treated with CSE or a selected compound for another 24 hours. This approach helped researchers ask whether the treatments could attenuate an established response, but it does not reproduce the lower, variable, and repeated exposures people may experience in everyday life.

Finally, the selected cell line primarily expresses ERα. Other estrogen-responsive receptors and signalling systems may behave differently. Animal studies, safety testing, dose-response work, and eventually carefully designed human research would all be needed before anyone could responsibly propose a health application.

The Bigger Opportunity Is Whole-Plant Hemp Research

The most immediate value of this work may be conceptual rather than therapeutic. Cannabis markets have trained consumers and producers to equate biological value with cannabinoid concentration. This study challenges that assumption. Its lead compounds were not THC or CBD, and the stems reportedly contained no detectable THC.

That opens a broader development path for hemp. A single crop might supply fibre, seeds, cannabinoid-rich material where legally permitted, and secondary compounds recovered from tissue that would otherwise receive little value. The economics are not proven, since extraction, purification, standardization, and safety testing could be costly. Still, identifying activity in a low-value stream is the first step toward determining whether recovery is commercially sensible.

The result also complements research into other neglected plant tissues. MyCannabis has previously examined how hemp root extracts affected inflammatory signalling in laboratory models. Taken together, these studies suggest that cannabis should be treated less like a flower with disposable supports and more like a chemically diverse biological system.

A Promising Signal, Not a Consumer Remedy

Cannabis stem extract disrupted BPA-driven estrogen signalling and cell proliferation through both receptor-related and MAPK/p38 mechanisms in a controlled cell model. The work is scientifically interesting because it identifies three non-cannabinoid compounds, reveals differences in how they may act, and assigns potential value to an underused part of the plant.

For consumers, however, there is no demonstrated supplement, dose, or protective benefit. Eating hemp products or using cannabis cannot be assumed to counter BPA exposure. The responsible conclusion is narrower but still worthwhile: discarded cannabis stems contain compounds capable of measurable biological activity, and they now warrant deeper investigation through more realistic exposure models.

If those later studies confirm efficacy, safety, and practical bioavailability, the stem could eventually become more than structural biomass. It could provide another example of how whole-plant research turns agricultural leftovers into starting points for useful materials and carefully validated health technologies.

References:

¹ Jeong, D.-H., Jeon, S. H., Hong, D. E., Lee, S.-H., Park, Y., Kim, J.-H., Park, Y., & Lee, H.-S. (2026). Cannabis sativa L. stem ethanol extract suppresses ERα-mediated endocrine disrupting effects induced by bisphenol A in a breast cancer cell line. Ecotoxicology and Environmental Safety, 324, 120832. https://doi.org/10.1016/j.ecoenv.2026.120832